Lv21
110 积分 2025-10-23 加入
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers
5小时前
已关闭
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers
5小时前
已完结
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
1个月前
已完结
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
1个月前
已完结
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas
1个月前
已完结
Multicenter randomized double-blind phase ll trial of donafenib in progressiveradioactive iodine-refractory differentiated thyroid cancer
1个月前
已完结
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma
2个月前
已完结
Histologic and Immunologic Factors Associated with Response to Immune Checkpoint Inhibitors in Advanced Sarcoma
4个月前
已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
4个月前
已完结
皖公网安备34019202002308
